Systematic Review and Meta-Analysis of the Impact of Computed Tomography–Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation

Freeman, 2002, The new liver allocation system: Moving toward evidence-based transplantation policy, Liver Transpl, 8, 851, 10.1053/jlts.2002.35927 Brown, 2004, Liver and intestine transplantation, Am J Transplant, 4, 81, 10.1111/j.1600-6135.2004.00400.x Myers, 2013, Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list, PLoS ONE, 8, e51926, 10.1371/journal.pone.0051926 Myers, 2014, Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list, Liver Int, 34, 1176, 10.1111/liv.12373 Lai, 2014, Frailty predicts waitlist mortality in liver transplant candidates, Am J Transplant, 14, 1870, 10.1111/ajt.12762 Levolger, 2015, Systematic review of sarcopenia in patients operated forresectable gastrointestinal and hepatopancreatobiliary malignancies, Br J Surg, 102, 1448, 10.1002/bjs.9893 Reisinger, 2015, Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery, Ann Surg, 261, 345, 10.1097/SLA.0000000000000628 van Vugt, 2015, Skeletal muscle depletion is associated with severe postoperative complications in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer, Ann Surg Oncol, 22, 3625, 10.1245/s10434-015-4429-z Moher, 2010, Group P. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement, Int J Surg, 8, 336, 10.1016/j.ijsu.2010.02.007 Wells GA, Shea B, O’connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014 [cited 2015 May 20]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 Bergerson, 2015, Liver transplantation arrests and reverses muscle wasting, Clin Transplant, 29, 216, 10.1111/ctr.12506 Cruz, 2013, Objective radiologic assessment of body composition in patients with end-stage liver disease: Going beyond the BMI, Transplantation, 95, 617, 10.1097/TP.0b013e31827a0f27 DiMartini, 2013, Muscle mass predicts outcomes following liver transplantation, Liver Transpl, 19, 1172, 10.1002/lt.23724 Durand, 2014, Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography, J Hepatol, 60, 1151, 10.1016/j.jhep.2014.02.026 Englesbe, 2010, Sarcopenia and mortality after liver transplantation, J Am Coll Surg, 211, 271, 10.1016/j.jamcollsurg.2010.03.039 Giusto, 2015, Sarcopenia in liver cirrhosis: The role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry, Eur J Gastroenterol Hepatol, 3, 328, 10.1097/MEG.0000000000000274 Hamaguchi, 2014, Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation, Liver Transpl, 20, 1413, 10.1002/lt.23970 Krell, 2013, Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation, Liver Transpl, 19, 1396, 10.1002/lt.23752 Lee, 2014, Dorsal muscle group area and surgical outcomes in liver transplantation, Clin Transplant, 28, 1092, 10.1111/ctr.12422 Masuda, 2014, Sarcopenia is a prognostic factor in living donor liver transplantation, Liver Transpl, 20, 401, 10.1002/lt.23811 Meza-Junco, 2013, Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma, J Clin Gastroenterol, 47, 861, 10.1097/MCG.0b013e318293a825 Montano-Loza, 2012, Muscle wasting is associated with mortality in patients with cirrhosis, Clin Gastroenterol Hepatol, 10, 166, 10.1016/j.cgh.2011.08.028 Montano-Loza, 2014, Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation, Liver Transpl, 20, 640, 10.1002/lt.23863 Tandon, 2012, Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value, Liver Transpl, 18, 1209, 10.1002/lt.23495 Toshima, 2015, Profile of plasma amino acids values as a predictor of sepsis in patients following living donor liver transplantation: Special reference to sarcopenia and postoperative early nutrition, Hepatol Res, 45, 1170, 10.1111/hepr.12484 Tsien, 2014, Post-liver transplantation sarcopenia in cirrhosis: A prospective evaluation, J Gastroenterol Hepatol, 29, 1250, 10.1111/jgh.12524 Valero, 2015, Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors, J Gastrointest Surg, 19, 272, 10.1007/s11605-014-2680-4 Waits, 2014, Morphometric age and mortality after liver transplant, JAMA Surg, 149, 335, 10.1001/jamasurg.2013.4823 Yadav, 2015, Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates, Clin Transplant, 29, 134, 10.1111/ctr.12493 Carey, 2014, Sarcopenia in solid organ transplantation, Nutr Clin Pract, 29, 159, 10.1177/0884533613520619 Kim, 2015, Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score, World J Gastroenterol, 21, 7637, 10.3748/wjg.v21.i25.7637 Montano-Loza, 2014, Muscle wasting: A nutritional criterion to prioritize patients for liver transplantation, Curr Opin Clin Nutr Metab Care, 17, 219, 10.1097/MCO.0000000000000046 Kamath, 2007, Advanced Liver Disease Study. The model for end-stage liver disease (MELD), Hepatology, 45, 797, 10.1002/hep.21563 Prado, 2008, Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study, Lancet Oncol, 9, 629, 10.1016/S1470-2045(08)70153-0 Martin, 2013, Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index, J Clin Oncol, 31, 1539, 10.1200/JCO.2012.45.2722 Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy (MENAC). 2015 [cited 2015 May 20]. Available from: https://clinicaltrials.gov/ct2/show/NCT02330926. Dingemans, 2014, Phase II drugs that are currently in development for the treatment of cachexia, Expert Opin Investig Drugs, 23, 1655, 10.1517/13543784.2014.942729 Kim, 2008, Hyponatremia and mortality among patients on the liver-transplant waiting list, N Engl J Med, 359, 1018, 10.1056/NEJMoa0801209 Montano-Loza, 2015, Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis, Clin Transl Gastroenterol, 6, e102, 10.1038/ctg.2015.31 Merli, 2010, Nutritional status: Its influence on the outcome of patients undergoing liver transplantation, Liver Int, 30, 208, 10.1111/j.1478-3231.2009.02135.x Selberg, 1997, Identification of high- and low-risk patients before liver transplantation: A prospective cohort study of nutritional and metabolic parameters in 150 patients, Hepatology, 25, 652, 10.1002/hep.510250327 Stephenson, 2001, Malnutrition in liver transplant patients: Preoperative subjective global assessment is predictive of outcome after liver transplantation, Transplantation, 72, 666, 10.1097/00007890-200108270-00018 Englesbe, 2012, Quantifying the eyeball test: Sarcopenia, analytic morphomics, and liver transplantation, Liver Transpl, 18, 1136, 10.1002/lt.23510 Fearon, 2011, Definition and classification of cancer cachexia: An international consensus, Lancet Oncol, 12, 489, 10.1016/S1470-2045(10)70218-7